pembrolizumab
merck
['pembro', 'bcsm']
interesting analysis of efs by rcb score in #kn522 just presented by l.pusztai. most benefit of pembro is observed among patients with rcb-2. pretty overlapping curves in rcb-1 and rcb-3.
#asco22 #bcsm 
MD, Research Fellow @DanaFarber | @harvardmed | @IEOufficiale | @LaStatale. Interested in breast oncology, HER2, ADCs & good music. Coffee expert.